NSCLC (non-small cell lung carcinoma)
Clinical trials for NSCLC (non-small cell lung carcinoma) explained in plain language.
Never miss a new study
Get alerted when new NSCLC (non-small cell lung carcinoma) trials appear
Sign up with your email to follow new studies for NSCLC (non-small cell lung carcinoma), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer pill takes on chemo in major trial
Disease control Recruiting nowThis Phase 3 trial is testing a new oral drug called daraxonrasib (RMC-6236) against the standard chemotherapy docetaxel in about 590 people with advanced non-small cell lung cancer that has a specific RAS mutation. Participants must have already tried at least one prior treatmen…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase 3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New combo therapy targets rare lung cancer mutation
Disease control Recruiting nowThis study tests a new drug (firmonertinib) combined with radiation therapy for people with a specific type of stage III lung cancer that cannot be removed by surgery. The cancer must have a rare change in the EGFR gene. The goal is to see if the combination can delay cancer grow…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase 2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC